Functional Consequences of Altering Myocardial Adrenergic Receptor Signaling
- 1 March 2000
- journal article
- review article
- Published by Annual Reviews in Annual Review of Physiology
- Vol. 62 (1) , 237-260
- https://doi.org/10.1146/annurev.physiol.62.1.237
Abstract
▪ Abstract From the ability to successfully manipulate the mouse genome has come important transgenic and gene-targeted knockout models that impact many areas of biomedical research. Genetically engineered mouse models geared toward the study of cardiovascular regulation have recently been described and provide powerful tools to study normal and compromised cardiac physiology. The genetic manipulation of the adrenergic receptor (AR) signaling system in the heart, including its regulation by desensitizing kinases, has shed light on the role of this signaling pathway in the regulation of cardiac contractility. One major finding, supported by several mouse models, is that in vivo contractility can be enhanced via alteration of myocardial AR signaling. Thus genetic manipulation of this critical receptor system in the heart represents a novel therapeutic approach for improving function of the failing heart.Keywords
This publication has 85 references indexed in Scilit:
- β-Adrenergic Receptor Kinase-1 Levels in Catecholamine-Induced Myocardial HypertrophyHypertension, 1999
- Cardiac-specific Overexpression ofα1BAR RegulatesβAR Activity Via Molecular CrosstalkJournal of Molecular and Cellular Cardiology, 1998
- Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted MicePublished by Elsevier ,1998
- Targeting the Receptor-G q Interface to Inhibit in Vivo Pressure Overload Myocardial HypertrophyScience, 1998
- Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice.Journal of Clinical Investigation, 1997
- G-protein-coupled receptor kinase activity is increased in hypertension.Journal of Clinical Investigation, 1997
- Phosphorylation and Activation of β-Adrenergic Receptor Kinase by Protein Kinase CJournal of Biological Chemistry, 1995
- Beta-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats.Hypertension, 1994
- Reduced beta 1 receptor messenger RNA abundance in the failing human heart.Journal of Clinical Investigation, 1993
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982